HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mitchell P Levesque Selected Research

Precision Medicine

10/2019VLA-4 mediated adhesion of melanoma cells on the blood-brain barrier is the critical cue for melanoma cell intercalation and barrier disruption.
1/2017Metastatic melanoma moves on: translational science in the era of personalized medicine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mitchell P Levesque Research Topics

Disease

98Melanoma (Melanoma, Malignant)
05/2024 - 04/2012
63Neoplasms (Cancer)
04/2024 - 04/2012
13Neoplasm Metastasis (Metastasis)
05/2024 - 01/2016
6Inflammation (Inflammations)
01/2023 - 02/2015
5Carcinogenesis
10/2023 - 11/2018
4Brain Neoplasms (Brain Tumor)
10/2021 - 01/2017
3Skin Neoplasms (Skin Cancer)
04/2024 - 01/2023
3Uveal melanoma
12/2023 - 01/2018
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2023 - 02/2015
2Hematologic Neoplasms (Hematological Malignancy)
01/2024 - 04/2016
2Wounds and Injuries (Trauma)
01/2023 - 01/2020
2Bites and Stings (Sting)
01/2022 - 01/2021
2Tertiary Lymphoid Structures
01/2022 - 01/2018
2Residual Neoplasm
01/2021 - 03/2015
2Testicular Neoplasms (Testicular Cancer)
10/2020 - 01/2019
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
04/2016 - 04/2014
1Lymphoma (Lymphomas)
01/2024
1Microsatellite Instability
08/2023
1Cachexia
01/2023
1Anorexia
01/2023
1Infections
12/2022
1COVID-19
12/2022

Drug/Important Bio-Agent (IBA)

17Immune Checkpoint InhibitorsIBA
02/2024 - 01/2018
16Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2015
15Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2018
12Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2024 - 01/2017
10RNA (Ribonucleic Acid)IBA
04/2024 - 01/2015
7CytokinesIBA
01/2023 - 03/2015
6Phosphotransferases (Kinase)IBA
01/2022 - 04/2012
5AntigensIBA
04/2024 - 01/2019
5ChemokinesIBA
01/2023 - 03/2015
4Adapalene (Differin)FDA LinkGeneric
12/2021 - 01/2014
4Mitogen-Activated Protein KinasesIBA
01/2021 - 03/2016
4CateninsIBA
01/2020 - 01/2018
3Peptides (Polypeptides)IBA
04/2024 - 01/2021
3IpilimumabIBA
02/2024 - 02/2013
3AntibodiesIBA
01/2024 - 01/2019
3NivolumabIBA
08/2023 - 11/2017
3DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2019
3InterferonsIBA
01/2022 - 01/2013
3Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
12/2021 - 12/2017
24- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
04/2024 - 02/2024
2ProteomeIBA
02/2024 - 01/2019
2HLA-A Antigens (HLA-A)IBA
12/2023 - 11/2017
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2023 - 07/2021
2ChromatinIBA
12/2023 - 01/2019
2Androgen Receptors (Androgen Receptor)IBA
10/2023 - 01/2021
2AnisomycinIBA
01/2023 - 01/2021
2Monophenol Monooxygenase (Tyrosinase)IBA
01/2023 - 01/2019
2Fatty Acids (Saturated Fatty Acids)IBA
01/2023 - 11/2019
2Transcription Factors (Transcription Factor)IBA
01/2023 - 11/2015
2LipidsIBA
01/2023 - 01/2017
2Imiquimod (Aldara)FDA LinkGeneric
01/2023 - 10/2021
2Adenosine Monophosphate (AMP)IBA
01/2022 - 12/2020
2Adenosine (Adenocard)FDA LinkGeneric
01/2022 - 12/2020
2Interleukin-12 (IL 12)IBA
10/2021 - 02/2015
2Programmed Cell Death 1 ReceptorIBA
12/2020 - 01/2018
2Glutathione (Reduced Glutathione)IBA
11/2020 - 11/2015
2SOXE Transcription FactorsIBA
01/2020 - 01/2015
2A-factor (Streptomyces)IBA
01/2020 - 01/2015
2Immunoglobulin G (IgG)IBA
01/2019 - 01/2019
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2024
1cyclopropapyrroloindoleIBA
04/2024
1Surface Antigens (Surface Antigen)IBA
01/2024
1Inositol (Myoinositol)IBA
01/2024
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2024
1tebentafuspIBA
12/2023
1AntioxidantsIBA
12/2023
1CalciumIBA
12/2023
1Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2023
15'- O- (9- phenylxanthen- 9- yl)- 2'- deoxynebularineIBA
10/2023
1Membrane Proteins (Integral Membrane Proteins)IBA
10/2023
1IntegrinsIBA
01/2023
1Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA
01/2023
1LigandsIBA
01/2023
1Chondroitin Sulfate ProteoglycansIBA
01/2023
1Bispecific AntibodiesIBA
01/2023
1Interleukin-15 (Interleukin 15)IBA
01/2023
1Sirolimus (Rapamycin)FDA Link
01/2023
1ElastinIBA
01/2023
1Growth Differentiation Factor 15IBA
01/2023
1Protein Synthesis InhibitorsIBA
01/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2023
1CollagenIBA
01/2023
1Chloroquine (Aralen)FDA LinkGeneric
01/2023
1stearoyl-coenzyme A (stearoyl-CoA)IBA
01/2023
1CD146 AntigenIBA
12/2022
1Circulating Tumor DNAIBA
08/2022
1S100 Proteins (S 100 Protein)IBA
08/2022
1Lipid Bilayers (Lipid Bilayer)IBA
06/2022
1MicroRNAs (MicroRNA)IBA
06/2022
1Peptide Hydrolases (Proteases)FDA Link
01/2022

Therapy/Procedure

53Therapeutics
01/2024 - 01/2013
23Immunotherapy
05/2024 - 02/2013
6Drug Therapy (Chemotherapy)
10/2023 - 01/2017
2Palliative Care (Palliative Therapy)
12/2022 - 01/2018
2Radiotherapy
05/2021 - 12/2020
2Precision Medicine
10/2019 - 01/2017
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2023
1Injections
12/2022